UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2604-2608

2015

Volltextzugriff (PDF)

Improving melanoma classification by integrating genetic and morphologic features

PLoS medicine, 2008-06, Vol.5 (6), p.e120-e120

2008

Volltextzugriff (PDF)

The many unanswered questions related to the German skin cancer screening programme

European journal of cancer (1990), 2016-09, Vol.64, p.83-88

2016

Volltextzugriff (PDF)

Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients

The Journal of immunology (1950), 2017-01, Vol.198 (2), p.927-936

2017

Volltextzugriff (PDF)

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

Journal of clinical oncology, 2013-03, Vol.31 (9), p.1211-1218

2013

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2010-01, Vol.46 (2), p.270-283

2010

Volltextzugriff (PDF)

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2823-2830

2009

Volltextzugriff (PDF)

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.180-180, Article 180

2019

Volltextzugriff (PDF)

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

European journal of cancer (1990), 2019-07, Vol.116, p.207-215

2019

Volltextzugriff (PDF)

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype

Molecular cancer, 2018-02, Vol.17 (1), p.59-59, Article 59

2018

Volltextzugriff (PDF)

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Cell death & disease, 2020-07, Vol.11 (7), p.581, Article 581

2020

Volltextzugriff (PDF)

Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition

Nature communications, 2024-10, Vol.15 (1), p.8750-9, Article 8750

2024

Volltextzugriff (PDF)

Antipsoriatika

Aktuelle Dermatologie, 2024-02, Vol.50 (1/02), p.84-86

2024

Volltextzugriff (PDF)

Salicylsäurehaltige Rezepturen

Aktuelle Dermatologie, 2024-02, Vol.50 (1/02), p.87-90

2024

Volltextzugriff (PDF)

Warzentherapeutika und Schälmittel (Peeling)

Aktuelle Dermatologie, 2023-11, Vol.49 (11), p.531-532

2023

Volltextzugriff (PDF)

Stomatologika

Aktuelle Dermatologie, 2023-10, Vol.49 (10), p.439-442

2023

Volltextzugriff (PDF)

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Journal of immunotherapy, 2009-06, Vol.32 (5), p.498-507

2009

Volltextzugriff (PDF)

Kortisonfreie Antiekzematosa

Aktuelle Dermatologie, 2023-09, Vol.49 (8/09), p.399-402

2023

Volltextzugriff (PDF)

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance

PloS one, 2011, Vol.6 (8), p.e23429

2011

Volltextzugriff (PDF)

Antihidrotika

Aktuelle Dermatologie, 2023-07, Vol.49 (7), p.335-336

2023

Volltextzugriff (PDF)

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

European journal of nuclear medicine and molecular imaging, 2018-01, Vol.45 (1), p.95-101

2018

Volltextzugriff (PDF)

Antipruriginosa

Aktuelle Dermatologie, 2023-06, Vol.49 (6), p.273-276

2023

Volltextzugriff (PDF)

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Clinical cancer research, 2017-10, Vol.23 (20), p.6203-6214

2017

Volltextzugriff (PDF)

Wundbehandlungsmittel

Aktuelle Dermatologie, 2023-05, Vol.49 (5), p.233-236

2023

Volltextzugriff (PDF)

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Acta dermato-venereologica, 2022-01, Vol.102, p.adv00637-adv00637

2022

Volltextzugriff (PDF)

26 – 50 von 964

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(783)
Mit Volltextzugriff
(831)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline

Improving melanoma classification by integrating genetic and morphologic features

The many unanswered questions related to the German skin cancer screening programme

Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition

Antipsoriatika

Salicylsäurehaltige Rezepturen

Warzentherapeutika und Schälmittel (Peeling)

Stomatologika

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Kortisonfreie Antiekzematosa

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance

Antihidrotika

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

Antipruriginosa

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Wundbehandlungsmittel

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Aktive Filter

Suchergebnisse filtern